Intravitreal Gene Therapy with LX102-C01 in Neovascular Age-Related Macular Degeneration: A Phase I Dose-Escalation Study of 12-Month Safety and Efficacy Outcomes
LX102-C01玻璃体内基因治疗新生血管性年龄相关性黄斑变性:一项为期12个月的I期剂量递增安全性和有效性研究
期刊:Ophthalmology Science
影响因子:4.6
doi:10.1016/j.xops.2025.100970
Sun, Junran; Shen, Mengxi; Chen, Jieqiong; Wu, Yidong; Zhou, Yanping; Feng, Jingyang; Cheng, Yuxuan; Jia, Huixun; Yang, Xiaolu; Gong, YuanYuan; Liu, Yang; Wang, Hong; Wang, Ruikang K; Rosenfeld, Philip J; Li, Tong; Wang, Fenghua; Sun, Xiaodong